Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus.
Very little information is available on human T cell responses following exposure to tick-borne encephalitis virus (TBEV) proteins, largely because the virus is a dangerous pathogen and relatively large amounts of purified antigen would be required for the functional characterization of cellular immune responses. We have produced recombinant TBEV proteins using the baculovirus expression system and tested them for their capacity to stimulate T cells in vitro. T lymphocytes from TBEV vaccinated individuals were characterized. The recombinant E and C proteins triggered CD4+ but not CD8+ cells to proliferate and to produce IFN-gamma and IL-5. T cell responses against recombinant NS3 protein were not detected. T cell lines with specificity for the E protein were also established. These lines were CD4+ and had a TH0 cytokine production pattern. Our results demonstrate the utility of recombinant viral proteins to study the generation and characterization of TBEV specific T cell responses.
Institute for Biomedical Ageing Research, Austrian Academy of Sciences, Innsbruck, Austria.
I
I
Gomez
F
F
Marx
M
M
Saurwein-Teissl
E A
EA
Gould
B
B
Grubeck-Loebenstein
D000956:Antigens, Viral / Q000008:administration & dosage / Q000235:genetics; D001483:Base Sequence; D016207:Cytokines / Q000096:biosynthesis; D004279:DNA, Viral / Q000235:genetics; D004669:Encephalitis Viruses, Tick-Borne / Q000235:genetics / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014611:Vaccination; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000302:isolation & purification
D000956:Antigens, Viral; D016207:Cytokines; D004279:DNA, Viral; D011994:Recombinant Proteins; D014764:Viral Proteins; D014765:Viral Vaccines